Allelix Biopharmaceuticals Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
  
 
C07K PEPTIDES 5131
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4163
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
5616481 Kainate-binding human CNS receptors of the EAA1 familyApr 03, 95Apr 01, 97[C12N, C07K]
5610032 AMPA-binding human GluR1 receptorsJun 06, 94Mar 11, 97[C12N]
5576314 Bicyclic nonane and decane compounds having dopamine receptor affinityDec 12, 94Nov 19, 96[A61K, C07D]
5574144 Kainate-binding, human CNS receptors of the EAA4 familyJun 24, 92Nov 12, 96[C07H, C12N]
5496801 Parathyroid hormone formulationDec 23, 93Mar 05, 96[A61K]
5420242 Production of human parathyroid hormone from microorganismsJul 02, 93May 30, 95[C12N, C07K]
5403825 Method for isolating a soluble osteogenic factor from boneSep 01, 92Apr 04, 95[A61K, C07K]
5382658 Stability-enhanced variants of parathyroid hormoneApr 03, 92Jan 17, 95[A61K, A01N, C07K]
5208041 Essentially pure human parathyroid hormoneMay 23, 91May 04, 93[A61K]
5169837 Isolated osteogenic factorMar 28, 91Dec 08, 92[A61K, C07K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2004/0167,158 Heterocyclic compounds for the treatment of migraineAbandonedFeb 24, 04Aug 26, 04[A61K, C07D]
6716837 Heterocyclic compounds for the treatment of migraineExpiredNov 13, 00Apr 06, 04[A61K, C07D, A61P]
2003/0228,665 Production of human parathyroid hormone from microorganismsAbandonedMay 14, 03Dec 11, 03[C07H, C12P, C12N, C07K]
2003/0139,589 G protein coupled receptor A4AbandonedFeb 01, 02Jul 24, 03[C12P, C12N, C07K]
2002/0169,182 Neurotrophin antagonist compositionsAbandonedJan 11, 01Nov 14, 02[A61K, C07D]
2002/0111,473 NOVEL G PROTEIN COUPLED RECEPTORAbandonedApr 16, 99Aug 15, 02[C07H, C12P, C12N, G01N]
2001/0049,441 Azaindoles having serotonin receptor affnityAbandonedDec 22, 00Dec 06, 01[C07D]
6103715 Dopamine receptor ligandsExpiredAug 25, 98Aug 15, 00[A61K, C07D]
6057126 Mammalian EDG-5 receptor homologsExpiredDec 24, 97May 02, 00[C07H, C12N]
6040175 AMPA-binding human GluR2 receptorsExpiredJun 07, 95Mar 21, 00[C12N, C07K]
6020158 Isolated polynucleotide for novel G-protein coupled receptorExpiredMay 22, 97Feb 01, 00[C07H, C12P, C12N]
6018023 Kainate-binding, human CNS receptors of the EAA3 familyExpiredJun 07, 95Jan 25, 00[C07K]
6013768 Kainate-binding human CNS receptors of the EAA1 familyExpiredJan 27, 97Jan 11, 00[C12N, C07K]
5998438 5-cyclo indole compoundsExpiredNov 21, 97Dec 07, 99[A61K, C07D]
5998462 5-alkyl indole compoundsExpiredDec 16, 96Dec 07, 99[A61K, C07D]
5968478 N- methyl piperazine compounds having dopamine receptor affinityExpiredOct 09, 97Oct 19, 99[A61K, A61M]
5856510 5-alkenyl and 5-alkynyl indole compoundsExpiredDec 16, 96Jan 05, 99[A61K, C07D]
5849734 Muscarinic receptor ligandsExpiredJun 11, 97Dec 15, 98[A61K, C07D]
5846823 Expression of human D4 dopamine receptors in stable cell linesExpiredMar 28, 96Dec 08, 98[C12N]
5834459 Alkyl-substituted compounds having dopamine receptor affinityExpiredApr 01, 96Nov 10, 98[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.